NIH-funded research NIH-funded research

How brain support cells affect neurons during morphine withdrawal

Official title: The molecular mechanisms of astrocytes-neurons interaction in the morphine use disorder

Funded at Miami VA Health Care System · NIH-11212755 · Data updated 2026-11-12

Looks at how astrocytes (brain support cells) and their signals change during morphine withdrawal in people with opioid use disorder.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionMiami VA Health Care System
NIH-funded
Lab location1 site (Miami, United States)
Project startOctober 1, 2022
Project endSeptember 30, 2026
Funding year2026
NIH project number5I01BX005114-04
Project IDNIH-11212755 on NIH RePORTER

Who could benefit from this research

Could help

People with opioid use disorder, particularly those experiencing morphine withdrawal and veterans receiving care for opioid problems, would be the most relevant candidates.

Less likely to help

People without opioid dependence or whose symptoms are not driven by neuroinflammation are unlikely to benefit directly.

What this research studies

From a patient's point of view, this project studies the biology behind morphine withdrawal by examining how astrocytes release inflammatory signals that change neuron behavior. The team will use laboratory and preclinical methods to measure a protein called LCN2 from astrocytes and its receptor on neurons in a brain region called the periaqueductal gray. They will also study epigenetic and mitochondrial markers in neurons, such as EZH2, pCREB, and Sirt3, and relate these molecular changes to withdrawal-related behaviors. The work aims to connect molecular signals to the physical and behavioral signs of withdrawal so new treatments can be developed.

Why it matters

Potential benefit: If successful, this work could reveal molecular targets that lead to new treatments to reduce morphine withdrawal symptoms and lower relapse risk.

How similar studies have gone: Previous animal and lab studies link astrocyte-driven inflammation to withdrawal, but targeting the LCN2–EZH2 pathway in this context is a newer approach with limited prior human data.

Where this research is happening

  • Miami VA Health Care System
    Miami, United States
    Active

Researchers

  • Principal investigator: Hao, Shuanglin — Miami VA Health Care System
  • Study coordinator: Hao, Shuanglin

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.